January 8, 2013 Study Questions Effectiveness of Therapy for Suicidal Teenagers By BENEDICT CAREY Most adolescents who plan or attempt suicide have already received at least some mental health treatment, raising questions about the effectiveness of current approaches to helping troubled youths, . . . Continue reading →
Today's news reports about an increase suicide rate in 2004 offer an opportunity to witness how the media unwittingly disseminates pharmaceutical industry generated propaganda. Continue reading →
Agence France Presse reports that suicide rates in Russia have decreased. Not surprisingly the highest suicide rate in Russia is in Siberia. Continue reading →
An investigative report in The Hartford Courant will undoubtedly lead to a Congressional investigation.
The report reveals that mentally unstable soldiers are being deployed to the Iraq front in violation of federal law. Continue reading →
GlaxoSmithKline Reverses Decade of Denial: in Clinical Trials Paxil Triggered Significantly More Suicide Attempts in Adults than Placebo Continue reading →
Psychiatric Adverse Events Associated with Drug Treatment of ADHD: Review of Postmarketing Safety Data Continue reading →
Dr. Peter Breggin’s sealed expert medical report in a Paxil liability case is now in the public domain.
Continue reading →
The UK adverse event drug reporting system utilizes the Yellow Card system for filing reports. Continue reading →
An analysis published in the current issue of the British J of Psychiatry (BJP) of the suicide rate among schizophrenia patients treated at the same hospital in North Wales (UK) before psychotropic drugs and patients treated (in and out of hospital) with neuroleptics and /or atypical antipsychotics, found a 20-fold increase in the suicide rate since use of psychotropic drugs.
Authors of the American College of Neuropsychopharmacology Task Force on SSRIs and Suicidal Behavior in Youth: their known ties to the pharmaceutical industry